307 related articles for article (PubMed ID: 27125300)
1. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
[TBL] [Abstract][Full Text] [Related]
2. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
[TBL] [Abstract][Full Text] [Related]
3. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
Padidela R; Camacho-Hübner C; Attie KM; Savage MO
Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
[TBL] [Abstract][Full Text] [Related]
4. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
Noordam C; Peer PG; Francois I; De Schepper J; van den Burgt I; Otten BJ
Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
[TBL] [Abstract][Full Text] [Related]
5. Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.
Libraro A; D'Ascanio V; Cappa M; Chiarito M; Digilio MC; Einaudi S; Grandone A; Maghnie M; Mazzanti L; Mussa A; Patti G; Scarano E; Spinuzza A; Vannelli S; Wasniewska MG; Ferrero GB; Faienza MF
Front Endocrinol (Lausanne); 2021; 12():761171. PubMed ID: 35002956
[TBL] [Abstract][Full Text] [Related]
6. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
7. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
[TBL] [Abstract][Full Text] [Related]
8. Noonan syndrome: growth to growth hormone - the experience of observational studies.
Ranke MB
Horm Res; 2009 Dec; 72 Suppl 2():36-40. PubMed ID: 20029235
[TBL] [Abstract][Full Text] [Related]
9. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
[TBL] [Abstract][Full Text] [Related]
10. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
Noonan JA; Kappelgaard AM
Horm Res Paediatr; 2015; 83(3):157-66. PubMed ID: 25503994
[TBL] [Abstract][Full Text] [Related]
12. Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database.
Raaijmakers R; Noordam C; Karagiannis G; Gregory JW; Hertel NT; Sipilä I; Otten BJ
J Pediatr Endocrinol Metab; 2008 Mar; 21(3):267-73. PubMed ID: 18540254
[TBL] [Abstract][Full Text] [Related]
13. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
Binder G
Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
[TBL] [Abstract][Full Text] [Related]
14. GH therapy in Noonan syndrome: Review of final height data.
Dahlgren J
Horm Res; 2009 Dec; 72 Suppl 2():46-8. PubMed ID: 20029237
[TBL] [Abstract][Full Text] [Related]
15. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
16. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of two doses of Norditropin
Horikawa R; Ogata T; Matsubara Y; Yokoya S; Ogawa Y; Nishijima K; Endo T; Ozono K
Endocr J; 2020 Aug; 67(8):803-818. PubMed ID: 32269181
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Effectiveness and Safety of Childhood Growth Hormone Treatment in Noonan Syndrome.
Rohrer TR; Abuzzahab J; Backeljauw P; Birkegård AC; Blair J; Dahlgren J; Júlíusson PB; Ostrow V; Pietropoli A; Polak M; Romano A; Ross J; Sävendahl L; Miller BS
Horm Res Paediatr; 2020; 93(6):380-395. PubMed ID: 33440388
[TBL] [Abstract][Full Text] [Related]
19. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
20. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.
Choi JH; Lee BH; Jung CW; Kim YM; Jin HY; Kim JM; Kim GH; Hwang JS; Yang SW; Lee J; Yoo HW
Horm Res Paediatr; 2012; 77(6):388-93. PubMed ID: 22777296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
